New lipid agents are high on potency, low on doc awareness

New lipid agents are high on potency, low on doc awareness

The new PCSK9 class of cholesterol-lowering antibodies continues to look promising, but many doctors—particularly PCPs—have never even heard of the experimental drugs.

Lack of marketing partner delays Afrezza launch

Lack of marketing partner delays Afrezza launch

Afrezza was heralded as one of the most innovative diabetes products of the last decade. So, why hasn't MannKind set a firm launch date for the product?

Rep access continues to shrink

Rep access continues to shrink

Sales reps are experiencing even more limited physician access, according to a report by Chicago consultancy ZS Associates.

Digital sage Richman returns to healthcare

He started the Dose of Digital blog in 2008, then left healthcare. Now, after more than two years away, Jonathan Richman says he's back in the business.

Haymarket launches psychiatry news, CME site

Haymarket Media launched the site PsychiatryAdvisor.com today.

CME commercial support cuts narrow

CME commercial support cuts narrow

The rate of decrease in industry's budget for continuing medical education (CME) slowed last year.

Industry trims support for CME

Industry reined in commercial support for CME in 2013—the sixth consecutive annual decrease—data released today by the ACCME show.

CMS plans to end CME Sunshine exemption

CMS plans to end CME Sunshine exemption

In what amounts to a sudden about face, CMS wants to delete the Sunshine rule's exclusion for continuing medical education.

Study reveals ways to fight antibiotic resistance

Study reveals ways to fight antibiotic resistance

The solution: talk to patients.

Merck rolls out MedEd website in India

The website is a joint effort between Merck and The Lancet.

Takeda releases internal probe over bad ad

An internal probe for a controversial ad for hypertension drug Blopress was released by Takeda, but the report is in Japanese.

Why the US Didn't Do Well at Lions Health

Why the US Didn't Do Well at Lions Health

A US Pharma juror's—and silver Lions Health winner's—opinion on why the Americans didn't fare well in Cannes, and tips for improvement

Ex ONC chief heads ACO group

Farzad Mostashari is leading a startup to help primary care physicians create Accountable Care Organizations

Everyday Health rolls out CancerRx app

Everyday Health rolls out CancerRx app

The bedside decision-making app includes clinical trial and drug information as well as breaking news.

CMS: docs can sign up for Sunshine peek

CMS: docs can sign up for Sunshine peek

Will docs line up to glimpse their payment data—and get a chance to correct mistakes—or will low awareness overshadow the latest milestone in the law's roll-out?

App can estimate blood loss

The maker of an FDA-approved app says its algorithm can use images to assess surgery-related blood loss.

WorldOne re-organizes, unifies around Sermo

WorldOne re-organizes, unifies around Sermo

The pharma market research major is working on unifying into one company with two main product lines, and is also in the process of a re-brand.

Texting threatens pagers, work-life balance

Texting HCPs may be speedy, but a study finds some built-in risks.

OPDP takes on sales aid for alcohol drug

OPDP takes on sales aid for alcohol drug

The advertising watchdog gave drugmaker Alvogen 15 days to make amends.

Teachable moment for new allergy tabs

Teachable moment for new allergy tabs

With pollen season approaching its peak, drugmakers are educating doctors on a new class of allergy tablets. It could be a while before they're made available for patients.

EHR deal puts Merck in the exam room

EHR deal puts Merck in the exam room

Merck's lead digital health strategist and his business partner offer a glimpse of what's possible through pharma and EHR collaborations.

Weight-loss drugs fight it out

Eisai announced it was adding sales reps to promote its drug Belviq, while Vivus, maker of Qsymia, fights off a generic marketing application by Actavis.

Poll finds most doctors OK with Iclusig

A survey by investment firm Jefferies found that the temporary 2013 suspension had a minimal impact on how doctors perceive the drug.

Research conflicts not limited to pharma

A piece about obesity and Coca-Cola shows the widespread nature of conflict-of-interest discussions and concerns about the sway that honoraria and other goodies may exert on researchers.

Meaningful use not linked to quality: study

Meaningful use not linked to quality: study

A recent study of physicians found no correlation between following EHR meaningful use requirements and providing consistently higher quality of care.

EHR use up 10%, as small practices tame data crunch

EHR use up 10%, as small practices tame data crunch

A report of over 270,000 US medical sites signals that EHR adoption is no longer a luxury reserved for hospitals and health systems.

Off-label guidance may not be publishing boon

Off-label guidance may not be publishing boon

The FDA's proposed upgrade to its off-label distribution guidelines has some new features, but experts say it is unclear if this means more dollars will flow toward reprints.

Doctors sound off on healthcare reform

They're not hiding their love or disdain for reform, including one who says the law brings bias into the exam room.

Health apps come up short in study

Health apps come up short in study

Researchers found that most healthcare apps have limited functionality, don't serve patients with multiple needs, and taper off when support is needed most. No wonder adoption is low.

Pharma eyes EHR for engaging with docs

Pharma eyes EHR for engaging with docs

EHRs could be a vehicle for pharma to find its way into the physician's workflow. First, industry needs to learn how to leverage them appropriately.

Intouch creates HCP content division

Intouch creates HCP content division

Growing client demand encouraged the agency to make its HCP content capabilities official.

Could EHR incentives draw pharma into exam room?

Could EHR incentives draw pharma into exam room?

How potential alignment between drug companies and physicians, via the EHR, could extend brand reach.

Study reveals doc detail preferences: Hang up the phone

Study reveals doc detail preferences: Hang up the phone

Doctors shared their information preferences with CMI/Compas, revealing ways marketers can better pace their communications to max out channels.

Medical students are digital, but not necessarily mobile

A survey by Athenahealth/ePocrates indicates that the digital habits of med students are in sync with those of their professional peers

A Parkinson's app for patients that took its cue from HCPs

A Parkinson's app for patients that took its cue from HCPs

Patient use of the professional app prompted the latest iteration, and the foundation behind it is set to launch a media push.

Pharma digerati launch advisory firm

Pharma digerati launch advisory firm

The duo whose nonprofit served as neutral ground for getting FDA and industry talking about digital marketing is starting a for-profit research and advisory firm.

Email Newsletters